small interfering RNA targeting NOD2

A **small interfering RNA targeting NOD2** is an experimental RNA interference therapeutic concept designed to reduce expression of **nucleotide-binding oligomerization domain-containing protein 2** by promoting sequence-specific degradation of NOD2 mRNA. In the provided literature context, NOD2 knockdown suppressed IL-8 secretion and reduced proliferation and invasion in clear cell renal cell carcinoma cell models, supporting NOD2 silencing as a potential anticancer strategy. However, no uniquely identified clinical drug candidate, sponsor, branded product, or development program was established from the supplied evidence, so this term is best treated as a non-specific preclinical NOD2-directed siRNA concept rather than a clearly defined named asset.

Other names

NOD2 siRNANOD-2 siRNANOD 2 siRNAsiRNA targeting NOD2